Retrovirology

official impact factor 5.24

Open Access Highly Access

Suppression of HIV-1 replication by microRNA effectors

Christine Chable-Bessia, Oussama Meziane, Daniel Latreille, Robinson Triboulet, Alessia Zamborlini, Alexandre Wagschal, Jean-Marc Jacquet, Jacques Reynes, Yves Levy, Ali Saib, Yamina Bennasser* and Monsef Benkirane*

Retrovirology 2009, 6:26 doi:10.1186/1742-4690-6-26

Accesses  

  • Last 30 days: 136 accesses
  • Last 365 days: 1413 accesses
  • All time: 6320 accesses

Cited by

BioMed Central: 4 citations

Research   Open Access Highly Accessed

Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients

Kenneth W Witwer, Andria K Watson, Joel N Blankson, Janice E Clements Retrovirology 2012, 9:5 (12 January 2012)

miRNA profiles, obtained using multiple acquisition, data processing, and analysis methods, distinguished ES and uninfected controls from viremic HIV-1-infected patients. For several miRNAs, however, ES and viremic patients shared similar expression patterns. Differentially expressed miRNAs included those with reported roles in HIV-1 latency (miR-29 family members, miRs -125b and -150). Others, such as miR-31 and miR-31*, had no previously reported connection with HIV-1 infection but were found here to differ significantly with uncontrolled HIV-1 replication.

Research   Open Access

Replication competent HIV-1 viruses that express intragenomic microRNA reveal discrete RNA-interference mechanisms that affect viral replication

Zachary Klase, Laurent Houzet, Kuan-Teh Jeang Cell & Bioscience 2011, 1:38 (23 November 2011)

Review   Open Access Highly Accessed

Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies

Laurence Colin, Carine Van Lint Retrovirology 2009, 6:111 (4 December 2009)

Minireview   Open Access Highly Accessed

Human cellular restriction factors that target HIV-1 replication

Klaus Strebel, Jeremy Luban, Kuan-Teh Jeang BMC Medicine 2009, 7:48 (16 September 2009)

Although different host cell factors act to inhibit viral replication and limit infection, HIV-1 has a number of measures to counteract this function; Strebel, Luban and Jeang review our current understanding of these interactions.